Nidan Laboratories & Healthcare Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2021 | Jun 2021 |
|---|---|---|
| Revenue | 16.53 | 7.85 |
| Operating Expense | 10.73 | 4.67 |
| Net Profit | 1.80 | 1.09 |
| Net Profit Margin | 10.89 | 13.89 |
| Earning Per Share | 1.82 | 1.10 |
| EBIDTA | 5.80 | 3.19 |
| Effective Tax Rate | 8.95 | 10.06 |
| Particulars | Sep 2021 |
|---|---|
| Revenue | 16.53 |
| Operating Expense | 10.73 |
| Net Profit | 1.80 |
| Net Profit Margin | 10.89 |
| Earning Per Share | 1.82 |
| EBIDTA | 5.80 |
| Effective Tax Rate | 8.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 24.18 | 24.27 | 29.66 |
| Operating Expenses Annual | 17.73 | 17.46 | 20.25 |
| Operating Profit Annual | 2.68 | 10.13 | 9.82 |
| Interest Annual | 2.18 | 2.22 | 2.66 |
| Depreciation | 2.87 | 3.10 | 2.63 |
| Net Profit Annual | -3.23 | 3.54 | 2.66 |
| Tax Annual | 0.86 | 1.27 | 1.86 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 24.18 |
| Operating Expenses Annual | 17.73 |
| Operating Profit Annual | 2.68 |
| Interest Annual | 2.18 |
| Depreciation | 2.87 |
| Net Profit Annual | -3.23 |
| Tax Annual | 0.86 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 8.42 | 8.10 | 7.30 |
| Cash Flow from Operations | -14.93 | 10.97 | 7.83 |
| Cash Flow from Investing | 9.84 | -0.29 | -35.74 |
| Cash Flow from Financing | -0.49 | -10.37 | 28.72 |
| Cash Flow at the End | 2.85 | 8.42 | 8.10 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 8.42 |
| Cash Flow from Operations | -14.93 |
| Cash Flow from Investing | 9.84 |
| Cash Flow from Financing | -0.49 |
| Cash Flow at the End | 2.85 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 38.01 | 41.74 | 33.07 |
| PBIT Margin (%) | 26.14 | 28.97 | 24.21 |
| PBT Margin (%) | 14.15 | 15.91 | 15.11 |
| Net PROFIT Margin (%) | -13.36 | 14.59 | 8.97 |
| Return On Networth / Equity (%) | -0.03 | 5.23 | 6.71 |
| Return On Networth /Employed (%) | 7.88 | 8.44 | 10.48 |
| Return On Assets (%) | -4.01 | 4.23 | 3.86 |
| Total Debt / Equity (X) | 0.17 | 0.22 | 0.72 |
| Asset Turnover Ratio (%) | 0.30 | 0.29 | 0.43 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 38.01 |
| PBIT Margin (%) | 26.14 |
| PBT Margin (%) | 14.15 |
| Net PROFIT Margin (%) | -13.36 |
| Return On Networth / Equity (%) | -0.03 |
| Return On Networth /Employed (%) | 7.88 |
| Return On Assets (%) | -4.01 |
| Total Debt / Equity (X) | 0.17 |
| Asset Turnover Ratio (%) | 0.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 17.95 | 21.39 | 20.46 |
| Total Current Assets Annual | 30.28 | 20.88 | 25.30 |
| Non Current Assets Annual | 52.27 | 63.52 | 63.18 |
| Total Shareholders Funds Annual | 66.21 | 69.44 | 65.90 |
| Total Assets Annual | 82.55 | 84.40 | 88.48 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 17.95 |
| Total Current Assets Annual | 30.28 |
| Non Current Assets Annual | 52.27 |
| Total Shareholders Funds Annual | 66.21 |
| Total Assets Annual | 82.55 |
No Data Availabe
